Analysis of Obesity GLP-1 Market by Key Country The obesity GLP-1 market is growing rapidly across major economies, with China and the United States both recording 25.4% CAGR through 2035, driven by large treatment-eligible populations and expanding access frameworks
For more details, please contact your healthcare provider.
We assess everything from adrenal health, energy levels, and metabolism to food sensitivities, nutrient deficiencies, and inflammation markers
Mechanistic insights into the role of GH and IGF-I secretion in age-related alterations in cognitive function were assessed in several preclinical studies by Sonntag and colleagues, demonstrating somatotropic effects on rodent brain aging (31)
Traditionally available only as injections, GLP1 receptor agonists have shown impressive results in lowering blood glucose, aiding in weight loss, and protecting the heart